Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma

被引：0
|
作者：
Sara E. Vazquez
Paul Bastard
Kathleen Kelly
Adrian Gervais
Philip J. Norris
Larry J. Dumont
Jean-Laurent Casanova
Mark S. Anderson
Joseph L. DeRisi
机构：
[1] University of California,Laboratory of Human Genetics of Infectious Diseases, Necker Branch
[2] INSERM U1163,St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch
[3] Necker Hospital for Sick Children,undefined
[4] University of Paris,undefined
[5] Imagine Institute,undefined
[6] The Rockefeller University,undefined
[7] Vitalant Research Institute,undefined
[8] University of Colorado School of Medicine,undefined
[9] Geisel School of Medicine at Dartmouth,undefined
[10] Howard Hughes Medical Institute,undefined
[11] Chan Zuckerberg Biohub,undefined
来源：
Journal of Clinical Immunology | 2021年 / 41卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1169 / 1171
页数：2
相关论文
共 50 条
  • [1] Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma
    Vazquez, Sara E.
    Bastard, Paul
    Kelly, Kathleen
    Gervais, Adrian
    Norris, Philip J.
    Dumont, Larry J.
    Casanova, Jean-Laurent
    Anderson, Mark S.
    DeRisi, Joseph L.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (06) : 1169 - 1171
  • [2] Autoantibodies Neutralizing Type I Interferons in 20% of COVID-19 Deaths in a French Hospital
    Chauvineau-Grenier, Angelique
    Bastard, Paul
    Servajean, Antoine
    Gervais, Adrian
    Rosain, Jeremie
    Jouanguy, Emmanuelle
    Cobat, Aurelie
    Casanova, Jean-Laurent
    Rossi, Benjamin
    JOURNAL OF CLINICAL IMMUNOLOGY, 2022, 42 (03) : 459 - 470
  • [3] Autoantibodies Neutralizing Type I Interferons in 20% of COVID-19 Deaths in a French Hospital
    Angélique Chauvineau-Grenier
    Paul Bastard
    Antoine Servajean
    Adrian Gervais
    Jérémie Rosain
    Emmanuelle Jouanguy
    Aurélie Cobat
    Jean-Laurent Casanova
    Benjamin Rossi
    Journal of Clinical Immunology, 2022, 42 : 459 - 470
  • [4] Autoantibodies neutralizing type III interferons are uncommon in patients with severe COVID-19 pneumonia
    Vanker, Martti
    Sarekannu, Karita
    Haljasmagi, Liis
    Kallaste, Anne
    Kisand, Kalle
    Lember, Margus
    Peterson, Part
    Kisand, Kai
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1695 - 1695
  • [5] Autoantibodies neutralizing type I interferons remain a significant risk factor for critical COVID-19 pneumonia in vaccinated patients
    Antoli, Arnau
    Gomez-Vazquez, Jose Luis
    Sierra-Fortuny, Angels
    Bermudez-Carre, Carla
    Framil, Mario
    Creus-Bachiller, Edgar
    Viana-Errasti, Julen
    Rofes, Paula
    Rocamora-Blanch, Gemma
    Hidalgo-Pena, Lara
    Garcia-Serrano, Lydia
    Rigo-Bonnin, Raul
    Feliubadalo, Lidia
    del Valle, Jesus
    Calatayud, Laura
    Morandeira, Francisco
    Lazaro, Conxi
    Solanich, Xavier
    CLINICAL IMMUNOLOGY, 2025, 276
  • [6] Measuring accuracy of the neutralizing activity of COVID-19 convalescent plasma
    Franchini, Massimo
    Mengoli, Carlo
    Caruso, Beatrice
    Petilino, Roberto
    Ballotari, Alessia
    Glingani, Claudia
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2022, 60 (01) : E4 - E6
  • [7] Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease
    Busnadiego, Idoia
    Abela, Irene A.
    Frey, Pascal M.
    Hofmaenner, Daniel A.
    Scheier, Thomas C.
    Schuepbach, Reto A.
    Buehler, Philipp K.
    Brugger, Silvio D.
    Hale, Benjamin G.
    PLOS BIOLOGY, 2022, 20 (07)
  • [8] Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19
    Eto, Shohei
    Nukui, Yoko
    Tsumura, Miyuki
    Nakagama, Yu
    Kashimada, Kenichi
    Mizoguchi, Yoko
    Utsumi, Takanori
    Taniguchi, Maki
    Sakura, Fumiaki
    Noma, Kosuke
    Yoshida, Yusuke
    Ohshimo, Shinichiro
    Nagashima, Shintaro
    Okamoto, Keisuke
    Endo, Akifumi
    Imai, Kohsuke
    Kanegane, Hirokazu
    Ohnishi, Hidenori
    Hirata, Shintaro
    Sugiyama, Eiji
    Shime, Nobuaki
    Ito, Masanori
    Ohge, Hiroki
    Kido, Yasutoshi
    Bastard, Paul
    Casanova, Jean-Laurent
    Ohara, Osamu
    Tanaka, Junko
    Morio, Tomohiro
    Okada, Satoshi
    JOURNAL OF CLINICAL IMMUNOLOGY, 2022, 42 (07) : 1360 - 1370
  • [9] Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19
    Shohei Eto
    Yoko Nukui
    Miyuki Tsumura
    Yu Nakagama
    Kenichi Kashimada
    Yoko Mizoguchi
    Takanori Utsumi
    Maki Taniguchi
    Fumiaki Sakura
    Kosuke Noma
    Yusuke Yoshida
    Shinichiro Ohshimo
    Shintaro Nagashima
    Keisuke Okamoto
    Akifumi Endo
    Kohsuke Imai
    Hirokazu Kanegane
    Hidenori Ohnishi
    Shintaro Hirata
    Eiji Sugiyama
    Nobuaki Shime
    Masanori Ito
    Hiroki Ohge
    Yasutoshi Kido
    Paul Bastard
    Jean-Laurent Casanova
    Osamu Ohara
    Junko Tanaka
    Tomohiro Morio
    Satoshi Okada
    Journal of Clinical Immunology, 2022, 42 : 1360 - 1370
  • [10] Role of Type I interferons in COVID-19
    Singh, Dhiraj K.
    Aladyeva, Ekaterina
    Singh, Bindu
    Alfson, Kendra J.
    Carrion, Ricardo
    Artyomov, Maxim A.
    Khader, Shabaana A.
    Kaushal, Deepak
    JOURNAL OF MEDICAL PRIMATOLOGY, 2023, 52 (05) : 340 - 340
12345